Cargando…

Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population

BACKGROUND: PPARG, PPARGC1A, and PPARGC1B polymorphisms may be implicated in the development of cancer. PARTICIPANTS AND METHODS: In this study, we selected PPARG rs1801282 C>G and rs3856806 C>T, PPARGC1A rs2970847 C>T, and PPARGC1B rs7732671 G>C and rs17572019 G>A single-nucleotide p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Jiang, Jiakai, Chen, Zhan, Wang, Yafeng, Tang, Weifeng, Chen, Yu, Liu, Longgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087028/
https://www.ncbi.nlm.nih.gov/pubmed/30122956
http://dx.doi.org/10.2147/OTT.S168274
_version_ 1783346599531905024
author Zhang, Sheng
Jiang, Jiakai
Chen, Zhan
Wang, Yafeng
Tang, Weifeng
Chen, Yu
Liu, Longgen
author_facet Zhang, Sheng
Jiang, Jiakai
Chen, Zhan
Wang, Yafeng
Tang, Weifeng
Chen, Yu
Liu, Longgen
author_sort Zhang, Sheng
collection PubMed
description BACKGROUND: PPARG, PPARGC1A, and PPARGC1B polymorphisms may be implicated in the development of cancer. PARTICIPANTS AND METHODS: In this study, we selected PPARG rs1801282 C>G and rs3856806 C>T, PPARGC1A rs2970847 C>T, and PPARGC1B rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk. A total of 584 HCC patients and 923 controls were enrolled. RESULTS: We found that PPARG rs1801282 C>G polymorphism was correlated with a decreased susceptibility of HCC (CG vs CC, adjusted OR 0.47, 95% CI 0.27–0.82, P=0.007; CG/GG vs CC, adjusted OR 0.52, 95% CI 0.31–0.88, P=0.015). However, PPARG rs3856806 C>T polymorphism was a risk factor for HCC (TT vs CC, adjusted OR 2.33, 95% CI 1.25–4.36, P=0.008; TT vs CT/CC, adjusted OR 2.26, 95% CI 1.22–4.17, P=0.010). In a subgroup analysis by chronic hepatitis B virus (HBV)-infection status, age, sex, alcohol use, and smoking status, a significant association between PPARG rs1801282 C>G polymorphism and a decreased risk of HCC in male, ≥53 years, never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups was found. However, we found PPARG rs3856806 C>T polymorphism increased the risk of HCC in never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups. Haplotype-comparison analysis indicated that C(rs1801282)T(rs3856806)C(rs2970847)G(rs7732671)G(rs17572019), C(rs1801282)T(rs3856806)T(rs2970847)G(rs7732671)G(rs17572019), and C(rs1801282)C(rs3856806)C(rs2970847)C(rs7732671)A(rs17572019) haplotypes increased the risk of HCC. PPARG C(rs1801282)T(rs3856806) and G(rs1801282)C(rs3856806) haplotypes also influenced the risk of HCC. CONCLUSION: In conclusion, our findings suggest PPARG polymorphisms may influence the susceptibility of HCC. The PPARG, PPARGC1A, and PPARGC1B haplotypes might be associated with HCC risk.
format Online
Article
Text
id pubmed-6087028
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-60870282018-08-17 Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population Zhang, Sheng Jiang, Jiakai Chen, Zhan Wang, Yafeng Tang, Weifeng Chen, Yu Liu, Longgen Onco Targets Ther Original Research BACKGROUND: PPARG, PPARGC1A, and PPARGC1B polymorphisms may be implicated in the development of cancer. PARTICIPANTS AND METHODS: In this study, we selected PPARG rs1801282 C>G and rs3856806 C>T, PPARGC1A rs2970847 C>T, and PPARGC1B rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk. A total of 584 HCC patients and 923 controls were enrolled. RESULTS: We found that PPARG rs1801282 C>G polymorphism was correlated with a decreased susceptibility of HCC (CG vs CC, adjusted OR 0.47, 95% CI 0.27–0.82, P=0.007; CG/GG vs CC, adjusted OR 0.52, 95% CI 0.31–0.88, P=0.015). However, PPARG rs3856806 C>T polymorphism was a risk factor for HCC (TT vs CC, adjusted OR 2.33, 95% CI 1.25–4.36, P=0.008; TT vs CT/CC, adjusted OR 2.26, 95% CI 1.22–4.17, P=0.010). In a subgroup analysis by chronic hepatitis B virus (HBV)-infection status, age, sex, alcohol use, and smoking status, a significant association between PPARG rs1801282 C>G polymorphism and a decreased risk of HCC in male, ≥53 years, never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups was found. However, we found PPARG rs3856806 C>T polymorphism increased the risk of HCC in never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups. Haplotype-comparison analysis indicated that C(rs1801282)T(rs3856806)C(rs2970847)G(rs7732671)G(rs17572019), C(rs1801282)T(rs3856806)T(rs2970847)G(rs7732671)G(rs17572019), and C(rs1801282)C(rs3856806)C(rs2970847)C(rs7732671)A(rs17572019) haplotypes increased the risk of HCC. PPARG C(rs1801282)T(rs3856806) and G(rs1801282)C(rs3856806) haplotypes also influenced the risk of HCC. CONCLUSION: In conclusion, our findings suggest PPARG polymorphisms may influence the susceptibility of HCC. The PPARG, PPARGC1A, and PPARGC1B haplotypes might be associated with HCC risk. Dove Medical Press 2018-08-08 /pmc/articles/PMC6087028/ /pubmed/30122956 http://dx.doi.org/10.2147/OTT.S168274 Text en © 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Sheng
Jiang, Jiakai
Chen, Zhan
Wang, Yafeng
Tang, Weifeng
Chen, Yu
Liu, Longgen
Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title_full Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title_fullStr Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title_full_unstemmed Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title_short Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
title_sort relationship of pparg, ppargc1a, and ppargc1b polymorphisms with susceptibility to hepatocellular carcinoma in an eastern chinese han population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087028/
https://www.ncbi.nlm.nih.gov/pubmed/30122956
http://dx.doi.org/10.2147/OTT.S168274
work_keys_str_mv AT zhangsheng relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT jiangjiakai relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT chenzhan relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT wangyafeng relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT tangweifeng relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT chenyu relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation
AT liulonggen relationshipofppargppargc1aandppargc1bpolymorphismswithsusceptibilitytohepatocellularcarcinomainaneasternchinesehanpopulation